PLGA-PEG microspheres of teverelix: Influence of polymer type on microsphere characteristics and on teverelix in vitro release

International Journal of Pharmaceutics

Volumn 261, Issue 1-2, 2003, Pages 69-80

  Mallardé, Delphine ^a   Boutignon, François ^a,c   Moine, Fabien ^a   Barré, Edith ^a   David, Sandrine ^a   Touchet, Hélène ^a   Ferruti, Paolo ^b   Deghenghi, Romano ^d  

^a Ardana   (France)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITÉ CLERMONT AUVERGNE   (France)

^d NONE

Author keywords

Coacervation; GnRH antagonists; In vitro release; Microspheres; PEG; PLGA PEG

Indexed keywords

COPOLYMER; GLYCOLIC ACID DERIVATIVE; MACROGOL; MICROSPHERE; POLY(LACTIC GLYCOLIC ACID); POLYMER; TEVERELIX; UNCLASSIFIED DRUG;

ARTICLE; COACERVATION; COMPARATIVE STUDY; DRUG RELEASE; ENCAPSULATION; GLASS TRANSITION TEMPERATURE; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR WEIGHT; PARTICLE SIZE; PRIORITY JOURNAL;

EID: 0042026308     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(03)00272-2     Document Type: Article

References (32)

1. Asano M., Fukuzaki H., Yoshida M., Kumakura M., Mashimo T., Yuasa H., Imai K., Yamanaka H., Suzuki K. In vivo characteristics of low molecular weight copoly(L-lactic acid/glycolic acid) formulations with controlled release of luteinizing hormone-releasing hormone agonist. J. Control. Rel. 9:1989;111-122.
2. Barrows, T.H., 1991. Synthetic bioabsorbably polymers. In: Szycher, M. (Ed.), High Performance Biomaterials: A Comprehensive Guide to Medical and Pharmaceutical Applications. Technomic Publishing, Lancaster, USA, pp. 243-258.
3. Boutignon, F., Touchet, H., Moine, F., Mallardé, D., David, S., Deghenghi, R., 1999. Sustained release formulation of the GnRH antagonist teverelix: in vivo and in vitro results. In: Proceedings of the 26th International Symposium on Control. Rel. Bioact. Mater. Abstract #5443, pp. 663-664.
4. Cleland J.L. Protein delivery from biodegradable microspheres. Pharm. Biotechnol. 10:1997;1-43.
5. Erb, K., Ruus, P., Schüler, A., Deghenghi, R., Hermann, R., 1999. Pharmacodynamic effects of single doses of teverelix in healthy men. Gynecol. Endocrinol., Suppl. 1, Abstract #67, 34 pp.
6. Ferruti, P., Penco, M., Ranucci, E., Bignotti, F., 1995a. High molecular weight polyester polycarbonates and the use thereof for the preparation of bioerodible matrices. WO95/12629, May 11.
7. Ferruti P., Penco M., D'Addato P., Ranucci E., Deghenghi R. Synthesis and properties of novel block copolymers containing poly(lactic-glycolic acid) and poly(ethylene glycol) segments. Biomaterials. 16:1995b;1423-1428.
8. Gilding D.K., Reed A.M. Biodegradable polymers for use in surgery - polyglycolic/poly(lactic acid) homo- and copolymers: 1. Polymer. 20:1979;1459-1464.
9. Jain R., Shah N.H., Malick A.W., Rhodes C.T. Controlled drug delivery by biodegradable poly(ester) devices: different preparative approaches. Drug Develop. Ind. Pharm. 24:1998;703-727.
10. Jain R., Rhodes C.T., Railkar A.M., Malick A.W., Shah N.H. Controlled release of drugs from injectable in situ formed biodegradable PLGA microspheres: effect of various formulation variables. Eur. J. Pharm. Biopharm. 50:2000;257-262.
11. Jalid R., Nixon J.R. Biodegradable poly(lactic acid) and poly(lactide-co-glycolide) microspheres: problems associated with preparative techniques and release properties. J. Microencapsul. 7:1990;297-325.
12. Lewis, D.H., 1990. Controlled release of bioactive agents from lactide/glycolide polymers. In: Chasin, M., Langer, R. (Eds.), Biodegradable Polymers as Drug Delivery Systems. Marcel Dekker, New York, pp. 1-41.
13. Medlicott N.J., Tucker I.G. Pulsatile release from subcutaneous implants. Adv. Drug Deliv. Rev. 38:1999;139-149.
14. Nihant N., Stassen S., Grandfils C., Jerôme R., Teyssié Ph. Microencapsulation by coacervation of poly(lactide-co-glycolide): II. Encapsulation of a dispersed aqueous phase. Polym. Int. 32:1993;171-176.
15. Nihant N., Stassen S., Grandfils C., Jérôme R., Teyssié Ph., Goffinet G. Microencapsulation by coacervation of poly(lactide-co-glycolide): III. Characterisation of the final microspheres. Polym. Int. 34:1994;289-299.
16. Nihant N., Grandfils C., Jérôme R., Teyssié Ph. Microencapsulation by coacervation of poly(lactide-co-glycolide): IV. Effect of the processing parameters on coacervation and encapsulation. J. Control. Rel. 35:1995;117-125.
17. Okada H. One and three-month release injectable microspheres of the LH-RH superagonist leuprorelin acetate. Adv. Drug Deliv. Rev. 28:1997;43-70.
18. Penco M., Ranucci E., Bignotti F., Ferruti P. New high-molecular-weight poly(ester-carbonates) by chain extension of poly(lactic-glycolic acid). Macromol. Rapid. Comm. 15:1994;683-690.
19. Penco M., Marcioni S., Ferruti P., D'Antone S., Deghenghi R. Degradation behaviour of block copolymers containing poly(lactic-glycolic acid) and poly(ethylene glycol) segments. Biomaterials. 17:1996a;1583-1590.
20. Penco M., Becattini M., Ferruti P., D'Antone S., Deghenghi R. Poly(ester-carbonates) containing poly(lactic-glycolic acid) and poly(ethylene glycol) segments. Polym. Adv. Technol. 7:1996b;536-542.
21. Ruiz J.M., Busnel J.P., Benoit J.P. Influence of average molecular weights of poly(D,L-lactic acid-co-glycolic acid) copolymers 50/50 on phase separation and in vitro drug release from microspheres. Pharm. Res. 7:1990;928-934.
22. Shameem M., Lee H., Burton K., Thanoo B.C., Deluca P.P. Effect of γ-irradiation on peptide-containing hydrophilic poly(D,L-lactide-co-glycolide) microspheres. PDA J. Pharm. Sci. Technol. 53:1999;309-313.
23. Stassen S., Nihant N., Martin V., Grandfils C., Jérome R., Teyssié Ph. Microencapsulation by coacervation of poly(lactide-co-glycolide): 1. Physico-chemical characteristics of the phase separation process. Polymer. 35:1994;777-785.
24. Szycher, M., 1991. Medical pharmaceutical markets for biomedical plastics. In: Szycher, M. (Ed.), High Performance Biomaterials: A Comprehensive Guide to Medical and Pharmaceutical Applications. Technomic Publishing, Lancaster, USA, pp. 3-30.
25. Thomasin C., Johansen P., Alder R., Bemsel R., Hottinger G., Altorfer H., Wright A.D., Wehrli G., Merkle H.P., Gander B. A contribution to overcoming the problem of residual solvents in biodegradable microspheres prepared by coacervation. Eur. J. Pharm. Biopharm. 42:1996;16-24.
26. Tice, T.R., Tabibi, E.S., 1991. Parenteral drug delivery: injectables applications. In: Kidonieus, A. (Ed.), Treatise on Controlled Drug Delivery: Fundamentals, Optimisation. Marcel Dekker, New York, pp. 315-339.
27. Vert M., Chabot F., Leray J., Christel P. Stereoregular bioresorbable polyesters for orthopaedic surgery. Macromol. Chem. Phys. Suppl. 5:1981;30.
28. Vert M., Li S., Garreau H. More about the degradation of LA/GA derived matrices in aqueous media. J. Control. Rel. 16:1991;15-26.
29. Witschi C., Doelker E. Influence of the microencapsulation method and peptide loading on poly(lactic acid) and poly(lactic-co-glycolic acid) degradation during in vitro testing. J. Control. Rel. 5:1998;327-341.
30. Wu, X.S., 1995a. Preparation, characterisation, and drug delivery applications of microspheres based on biodegradable lactic/glycolic acid polymers. In: Wise, D.L., Trantolo, D.J., Altobelli, D.E., Yaszemski, M.J., Gresser, J.D., Schwartz, E.R. (Eds.), Encyclopaedic Handbook of Biomaterials and Bioengineering. Marcel Dekker, New York, pp. 1015-1054.
31. Wu, X.S., 1995b. Preparation, characterisation, and drug delivery applications of microspheres based on biodegradable lactic/glycolic acid polymers. In: Wise, D.L., Trantolo, D.J., Altobelli, D.E., Yaszemski, M.J., Gresser, J.D., Schwartz, E.R. (Eds.), Encyclopaedic Handbook of Biomaterials and Bioengineering. Marcel Dekker, New York, pp. 1151-1200.
32. Zhu K.J., Xiangzhou L., Shilin Y. Preparation, characterization, and properties of polylactide (PLA)-poly(ethylene glycol) (PEG) copolymers: a potential drug carrier. J. Appl. Polym. Sci. 39:1990;1-9.